PARSIPPANY, N.J.--(BUSINESS WIRE)--July 25, 2006--The Medicines Company (NASDAQ: MDCO - News) today announced its financial results for the second quarter and first half of 2006. John Kelley, President and Chief Operating Officer, said, "Demand for Angiomax is accelerating, fueled by the productivity of our sales force. We continue to make progress on our pipeline products, and we remain on track with Phase III trial goals. Our acute care franchise is taking shape."
